Prudential Financial Inc Alx Oncology Holdings Inc Transaction History

Prudential Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.52 - $11.71 $18,080 - $46,840	4,000 Added 21.3%	22,780 $102,000
Q4 2022 Feb 14, 2023	SELL	$9.51 - $12.95 $131,238 - $178,710	-13,800 Reduced 42.36%	18,780 $0
Q3 2022 Nov 04, 2022	SELL	$8.23 - $15.14 $45,347 - $83,421	-5,510 Reduced 14.47%	32,580 $312,000
Q2 2022 Aug 15, 2022	BUY	$5.89 - $19.46 $224,350 - $741,231	38,090 New	38,090 $308,000
Q4 2021 Feb 14, 2022	SELL	$21.49 - $74.4 $211,569 - $732,468	-9,845 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$52.2 - $75.23 $385,236 - $555,197	-7,380 Reduced 42.84%	9,845 $538,000
Q1 2021 May 12, 2021	BUY	$62.84 - $87.68 $422,284 - $589,209	6,720 Added 63.97%	17,225 $1.27 Million
Q4 2020 Feb 16, 2021	BUY	$34.11 - $112.26 $11,426 - $37,607	335 Added 3.29%	10,505 $906,000
Q3 2020 Nov 16, 2020	BUY	$29.36 - $47.1 $298,591 - $479,007	10,170 New	10,170 $384,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.